Literature DB >> 16274557

An assessment of the first 3 years' use of Implanon in Luton.

Anjali Agrawal1, Christine Robinson.   

Abstract

OBJECTIVES: Implanon was introduced in the UK in September 1999. We present here the results of our first 106 Implanon insertions, performed over a period of 18 months. The aims of the study were to study the clinical and demographic profile of Implanon users, to assess the continuation rates of Implanon in the local population, and to identify the reasons for removal.
METHODS: This was a case note-based study in which the data were transferred to a standardised pre-tested proforma.
RESULTS: The age range of the 106 Implanon users was 15-43 years. Eighty-six of these clients had their Implanon removed and the Implanon status of 20 clients is not known since they were lost to follow-up by our service. Of these 86 cases, 26 had completed the full 3-year period; therefore, the continuation rate at 3 years was 30.2%. The continuation rate at the end of 1 year was 69.8% and at 2 years was 44.1%. Of the 60 women who had their Implanon removed before the recommended 3-year period, the most common reason was for bleeding irregularity (24 cases, 40%).
CONCLUSIONS: This is the first published study set in the UK within a real-life setting to follow up a cohort of Implanon users for the full 3-year period. No contraceptive failures were found, replicating previous clinical trials. The continuation rate in this real-life situation was quite low compared to clinical trials. This is frequently the case when comparing real-life situations with clinical trials and may be in part due to higher motivation on the part of clinical trial participants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274557     DOI: 10.1783/147118905774480581

Source DB:  PubMed          Journal:  J Fam Plann Reprod Health Care        ISSN: 1471-1893


  6 in total

Review 1.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

2.  Three-year continuation of reversible contraception.

Authors:  Justin T Diedrich; Qiuhong Zhao; Tessa Madden; Gina M Secura; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2015-08-07       Impact factor: 8.661

Review 3.  Current and future contraceptive options for women living with HIV.

Authors:  Rena C Patel; Elizabeth A Bukusi; Jared M Baeten
Journal:  Expert Opin Pharmacother       Date:  2017-09-19       Impact factor: 3.889

Review 4.  Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.

Authors:  Rena C Patel; Chelsea Morroni; Kimberly K Scarsi; Tabitha Sripipatana; James Kiarie; Craig R Cohen
Journal:  J Int AIDS Soc       Date:  2017-05-11       Impact factor: 5.396

5.  A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.

Authors:  Kusum V Moray; Himanshu Chaurasia; Oshima Sachin; Beena Joshi
Journal:  Reprod Health       Date:  2021-01-06       Impact factor: 3.223

6.  Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia.

Authors:  Abreham Nageso; Achamyelesh Gebretsadik
Journal:  BMC Womens Health       Date:  2018-11-20       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.